QGEN NYSE Week ended 31 Jul 2026

Weekly Investor Report

Qiagen NV · Healthcare · Diagnostics & Research

Open interactive chart View report data
Latest close 41.40 USD
0.1% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -1.2% below the Trend Line and sits at 35.1% of its 52-week range. The latest completed week returned 0.1%, after a 4.2% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 42 out of 100
Latest Close 41.40 USD 31 Jul 2026
1W Return 0.1% latest completed week
4W Return 4.2% short-term follow-through
12W Return 25.3% quarterly tape
Trend Breadth 36.5% 19 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.1% Latest completed week; four-week move 4.2%. Indicator stack 20/91 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 52/100 conviction; expected move 14.7%. News sentiment 55/100 55 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -1.2% below the Trend Line and sits at 35.1% of its 52-week range. The latest completed week returned 0.1%, after a 4.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1812-week average 0.07

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 4.2% over four weeks, 25.3% over 12 weeks, and -17.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.1%
4W4.2%
12W25.3%
26W-22.9%
52W-17.5%
Active trend streak0 weeks
Active weeks in one year19
Trend breadth36.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.76Latest activity-pressure read.
Pressure change337.5%Four-week change in activity pressure.
Leadership-13.96Latest relative-leadership reading.
RS change28.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength23/100Blend of value, momentum, and quality. Underlying universe rank 78; rank 1 is best.
Value23/100Relative valuation strength. Underlying universe rank 78; rank 1 is best.
Quality90/100Profitability and accounting quality. Underlying universe rank 11; rank 1 is best.
Momentum15/100Medium-term price momentum. Underlying universe rank 86; rank 1 is best.
Growth74/100Revenue and earnings growth. Underlying universe rank 27; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework48/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
21.2x
Price divided by trailing earnings.
Price / sales
4.1x
Market value relative to trailing revenue.
EV / EBITDA
12.3x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
8.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
61.6%
Gross profit retained from each unit of revenue.
Operating margin
23.5%
Operating profit retained from revenue.
Free-cash-flow margin
39.1%
Free cash flow generated from revenue.
Return on invested capital
10.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
4.8%
Latest one-year revenue growth.
EPS growth
329.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-4.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.8%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

QGEN shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.10, expected move of 14.7%, and Sharemaestro trend signal inactive.

Conviction52/100
Expected move14.7%
Put/call volume0.10
Pressure92
Speculation20
Volatility87
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 55 relevant articles.

16 positive · 35 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move14.7%Nearest-chain priced movement where available.
52-week drawdown-28.4%Distance below the 52-week high.
13-week volatility2.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+6.7%Week of 26 Jun.
Worst week-10.8%Week of 1 May.
Latest week+0.1%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains6
Flat weeks0
Modest losses10
Sharp losses5
Recent vol2.9%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew3.4% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape36/100

Trend, activity pressure, participation, and risk combine to a 36/100 tape read.

 Indicator analysis20/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.

Activity pressure 0.18; No reversal markers Factors38/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 66; Small Cap Core rank 76 SVQF48/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 530.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options35/100

QGEN shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.10, expected move of 14.7%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 14.7% Sentiment55/100

Weighted news tone is neutral across 55 relevant articles.

Qiagen (QGEN) Stock Could Be A Cash Flow Bargain Yet Fair On Earnings Insiders50/100

No recent insider transaction evidence is stored.

 Earnings2d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202641.40 USD0.1%41.89 USD43.43 USD0.76-13.969.4MOff
24 Jul 202641.37 USD0.5%42.02 USD43.46 USD0.75-13.7510.9MOff
17 Jul 202641.15 USD-0.9%42.16 USD43.50 USD0.79-15.3813.2MOff
10 Jul 202641.51 USD4.5%42.32 USD43.53 USD0.57-16.5224.7MOff
3 Jul 202639.74 USD1.8%42.45 USD43.56 USD0.17-19.549.7MOff
26 Jun 202639.06 USD6.7%42.70 USD43.60 USD-0.16-19.8015.8MOff
19 Jun 202636.62 USD-0.3%43.00 USD43.63 USD-0.58-27.119.4MOff
12 Jun 202636.73 USD1.0%43.34 USD43.69 USD-0.86-26.8610.7MOff
5 Jun 202636.35 USD-0.7%43.60 USD43.75 USD-1.01-27.8111.9MOff
29 May 202636.59 USD4.0%43.85 USD43.81 USD-1.14-29.708.9MOff
22 May 202635.17 USD6.6%44.20 USD43.88 USD-1.14-32.009.7MOff
15 May 202632.98 USD-0.2%44.68 USD43.95 USD-1.11-36.1414.3MOff
8 May 202633.04 USD-3.5%45.20 USD44.03 USD-1.10-36.389.4MOff
1 May 202634.25 USD-10.8%45.67 USD44.10 USD-1.04-33.0519.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.